Hsbc Global Res Upgrades Roche (OTCMKTS:RHHBY) to “Strong-Buy”

Roche (OTCMKTS:RHHBY) was upgraded by stock analysts at Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday,Zacks.com reports.

Separately, HSBC upgraded Roche from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a research note on Thursday. Three analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Roche currently has an average rating of “Buy” and an average target price of $50.00.

Roche Stock Performance

OTCMKTS:RHHBY opened at $44.70 on Thursday. Roche has a 12-month low of $34.10 and a 12-month high of $45.08. The stock’s 50 day moving average price is $40.68 and its two-hundred day moving average price is $40.26.

Hedge Funds Weigh In On Roche

A number of large investors have recently made changes to their positions in RHHBY. GAMMA Investing LLC boosted its stake in Roche by 6,463.8% in the 1st quarter. GAMMA Investing LLC now owns 528,778 shares of the company’s stock valued at $21,759,000 after purchasing an additional 520,722 shares during the period. Boston Common Asset Management LLC lifted its holdings in shares of Roche by 11.1% during the second quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock worth $14,682,000 after buying an additional 36,101 shares in the last quarter. OLD National Bancorp IN lifted its holdings in shares of Roche by 2.9% during the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after buying an additional 7,326 shares in the last quarter. Altrius Capital Management Inc boosted its position in shares of Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock valued at $7,818,000 after acquiring an additional 6,545 shares during the period. Finally, Bard Financial Services Inc. grew its stake in shares of Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock valued at $5,716,000 after acquiring an additional 28,050 shares in the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.